title: Does the targeted delivery of theranostic carbon nanotubes have potential as a valid anticancer strategy?
authors.affiliation: Departments of Neurology & Biomedical Research Imaging Centre, 130 Mason Farm Road, University of North Carolina, Chapel Hill, NC 27599, USA. manasmita_das@med.unc.edu.
authors.forename: Manasmita
authors.initials: M
authors.lastname: Das
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D004337:Drug Carriers; D016503:Drug Delivery Systems; D006801:Humans; D036103:Nanotechnology; D037742:Nanotubes, Carbon; D009369:Neoplasms / Q000188:drug therapy*; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D037742:Nanotubes, Carbon